sumatriptan
In a multicenter study, a long-term analysis was made of the efficacy, safety,       and tolerability of subcutaneous (s.c.) sumatriptan in the acute treatment of       migraine attacks over a period of up to 18 months.
In a multicenter study, a long-term analysis was made of the efficacy, safety,       and tolerability of subcutaneous (s.c.)  @SUBJECT$  in the acute  @PREDICAT$  of        @OBJECT$  attacks over a period of up to 18 months.